Gt biopharma to present at raymond james human health innovation conference

Beverly hills, calif., june 16, 2021 /prnewswire/ -- gt biopharma, inc. ("gt biopharma" or the "company") (nasdaq: gtbp), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (nk) cell engager (trike™) protein biologic technology platform, today announced that it will provide a corporate update at the upcoming raymond james human health innovation conference on tuesday, june 22, 2021 at 11:20 am et.
GTBP Ratings Summary
GTBP Quant Ranking